CAMBRIDGE, Mass., May 24, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, announced today that the company will participate in the Deutsche Bank 38th Annual Health Care Conference in Boston. Marc Beer, Chief Executive Officer of Aegerion, is scheduled to present on Thursday, May 30th, 2013 at 8:00 a.m. ET.
Aegerion will also participate in the Jefferies 2013 Global Healthcare Conference in New York City. Mr. Beer is scheduled to present on Tuesday, June 4, 2013 at 2:30 p.m. ET.
Both presentations will be webcast live and may be accessed for up to 30 days following the conference by visiting the "Investors" section of Aegerion's website, www.aegerion.com.
About Aegerion Pharmaceuticals
Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating, often fatal, rare diseases. For more information about the company, please visit www.aegerion.com.